yes Speckled... details are always the issue.. firstly ... what a "horrible" problem to have eh ..?? lol... and secondly.. if it is just AUS market for REMPLIR ... that equates to about 11,000 procedures a year from company info given .. I'd say that would be able to be managed wit recent manufacturing upgrade as Striate likely not to go immediately to 100,000 a year production rate ... but who knows... lets see the info on announcement when it comes... but one thing we do know is that as this is a platform product... this will improve margin $ on product as they have already said before ...
OCC Price at posting:
40.0¢ Sentiment: Buy Disclosure: Held
